Cargando…

Diagnostic and Prognostic Significance of the Prothrombin Time/International Normalized Ratio in Sepsis and Septic Shock

OBJECTIVE: The study investigates the diagnostic and prognostic significance of the prothrombin time/international normalized ratio (PT/INR) in patients with sepsis and septic shock. BACKGROUND: Sepsis may be complicated by disseminated intravascular coagulation (DIC). While the status of coagulopat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schupp, Tobias, Weidner, Kathrin, Rusnak, Jonas, Jawhar, Schanas, Forner, Jan, Dulatahu, Floriana, Brück, Lea Marie, Hoffmann, Ursula, Bertsch, Thomas, Müller, Julian, Weiß, Christel, Akin, Ibrahim, Behnes, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Manuscript
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749050/ https://www.ncbi.nlm.nih.gov/pubmed/36503298 http://dx.doi.org/10.1177/10760296221137893

Ejemplares similares

C-reactive protein and procalcitonin during course of sepsis and septic shock
por: Schupp, Tobias, et al.
Publicado: (2023)

Cardiac Troponin I Reveals Diagnostic and Prognostic Superiority to Aminoterminal Pro-B-Type Natriuretic Peptide in Sepsis and Septic Shock
por: Forner, Jan, et al.
Publicado: (2022)

Diagnostic and Prognostic Performance of Plasma Albumin and Cholinesterase in Patients with Sepsis and Septic Shock
por: Schupp, Tobias, et al.
Publicado: (2023)

Cardiac Troponin I but Not N-Terminal Pro-B-Type Natriuretic Peptide Predicts Outcomes in Cardiogenic Shock
por: Schupp, Tobias, et al.
Publicado: (2023)

C-Reactive Protein and White Blood Cell Count in Cardiogenic Shock
por: Dudda, Jonas, et al.
Publicado: (2023)

Prognostic Value of the AST/ALT Ratio versus Bilirubin in Patients with Cardiogenic Shock
por: Schupp, Tobias, et al.
Publicado: (2023)

Differences in Outcome of Patients with Cardiogenic Shock Associated with In-Hospital or Out-of-Hospital Cardiac Arrest
por: Rusnak, Jonas, et al.
Publicado: (2023)

Effect of Cardiovascular Risk Factors on 30-Day All-Cause Mortality in Cardiogenic Shock
por: Forner, Jan, et al.
Publicado: (2023)

Impact of Lactate on 30-Day All-Cause Mortality in Patients with and without Out-of-Hospital Cardiac Arrest Due to Cardiogenic Shock
por: Rusnak, Jonas, et al.
Publicado: (2022)

Carvedilol versus Metoprolol in Patients with Ventricular Tachyarrhythmias
por: Schupp, Tobias, et al.
Publicado: (2022)

Prognostic Impact of Different Types of Ventricular Tachyarrhythmias Stratified by Underlying Cardiac Disease
por: Schupp, Tobias, et al.
Publicado: (2022)

Prognostic Value of Cardiac Troponin I in Patients with Ventricular Tachyarrhythmias
por: Akin, Ibrahim, et al.
Publicado: (2022)

Does Albumin Predict the Risk of Mortality in Patients with Cardiogenic Shock?
por: Schupp, Tobias, et al.
Publicado: (2023)

Angiotensin Converting Enzyme Inhibitors versus Receptor Blockers in Patients with Ventricular Tachyarrhythmias
por: Schupp, Tobias, et al.
Publicado: (2022)

TIMP-1 gene polymorphism: are genetics able to predict outcome of septic patients?
por: Behnes, Michael, et al.
Publicado: (2013)

Diagnostic value of Pentraxin-3 in patients with sepsis and septic shock in accordance with latest sepsis-3 definitions
por: Hamed, Sonja, et al.
Publicado: (2017)

Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment
por: Behnes, Michael, et al.
Publicado: (2014)

High Sensitivity Troponins Discriminate Different Morphologies of Coronary Artery Plaques Being Assessed by Coronary Computed Tomography Angiography
por: Rusnak, Jonas, et al.
Publicado: (2017)

Type 2 diabetes is independently associated with all-cause mortality secondary to ventricular tachyarrhythmias
por: Weidner, Kathrin, et al.
Publicado: (2018)

Neural correlates of affective stimulus evaluation: a case-by-case analysis
por: Schupp, Harald T, et al.
Publicado: (2021)

Prothrombin Time and Coagulation Factor IX as Hemostatic Risk Markers for Legg– Calvé–Perthes Disease
por: Hernández-Zamora, Edgar, et al.
Publicado: (2023)

Retrospective Comparison of Andexanet Alfa and 4-Factor Prothrombin Complex for Reversal of Factor Xa-Inhibitor Related Bleeding
por: Stevens, Victoria M., et al.
Publicado: (2021)

Comparative analysis of high-sensitivity cardiac troponin I and T for their association with coronary computed tomography-assessed calcium scoring represented by the Agatston score
por: Rusnak, Jonas, et al.
Publicado: (2017)

Activated Partial Thromboplastin Time or Prothrombin Time Prolongation During Rivaroxaban Administration: Clinical Risk Factors and Outcomes Analysis
por: Yuan, Yao, et al.
Publicado: (2023)

Association between admission serum procalcitonin and the occurrence of acute kidney injury in patients with septic shock: A retrospective cohort study
por: Hu, Qinghe, et al.
Publicado: (2021)

Prognostic Values of Prothrombin Time and Inflammation-Related Parameter in Acute Ischemic Stroke Patients After Intravenous Thrombolysis with rt-PA
por: Zhao, Jingru, et al.
Publicado: (2023)

Impact of age on the prognosis of patients with ventricular tachyarrhythmias and aborted cardiac arrest
por: Weidner, Kathrin, et al.
Publicado: (2022)

Andexanet Alfa Versus Prothrombin Complex Concentrates/Blood Products as Apixaban/Rivaroxaban Reversal Agents: A Survey Among Pediatric Hematologists
por: Rodriguez, Vilmarie, et al.
Publicado: (2022)

Retrospective Analysis of the Real-World Utilization of 4-Factor Prothrombin Complex Concentrate and Plasma in Oral Anticoagulant-Associated Bleeding in US Hospitals
por: Refaai, Majed A., et al.
Publicado: (2023)

Outcomes of 4-factor Prothrombin Complex Concentrate in Patients With Liver Disease and Nonvitamin K Antagonist-Related Coagulopathy: A Retrospective Study
por: Dodhiawala, Paarth B., et al.
Publicado: (2023)

Cardiac disease and prognosis associated with ventricular tachyarrhythmias in young adults and adults
por: Weidner, Kathrin, et al.
Publicado: (2022)

Statin therapy is associated with improved survival in patients with ventricular tachyarrhythmias
por: Rusnak, Jonas, et al.
Publicado: (2019)

Galectin-3 Reflects the Echocardiographic Grades of Left Ventricular Diastolic Dysfunction
por: Ansari, Uzair, et al.
Publicado: (2018)

Plasminogen activator inhibitor-1, thrombin-antithrombin, and prothrombin fragment F1+2 have higher diagnostic values than D-dimer for venous thromboembolism after TKA
por: Yang, Yong, et al.
Publicado: (2022)

Role of thromboelastography in the evaluation of septic shock patients with normal prothrombin time and activated partial thromboplastin time
por: Kim, Sang-Min, et al.
Publicado: (2021)

Atrial Fibrillation Is Associated with Increased Mortality in Patients Presenting with Ventricular Tachyarrhythmias
por: Behnes, Michael, et al.
Publicado: (2019)

Patients’ Plasma Activity of Heparin, low-Molecular-Weight Heparin or no Anticoagulants on Urine Based DOAC Test Strips
por: Harenberg, Job, et al.
Publicado: (2022)

Prognostic value of beta-blocker doses in patients with ventricular tachyarrhythmias
por: Schupp, Tobias, et al.
Publicado: (2022)

Pharmacological Treatment Following Myocardial Infarction: How Large Is the Gap Between Guideline Recommendations and Routine Clinical Care?
por: Schupp, Tobias, et al.
Publicado: (2021)

Special Issue: Sudden Cardiac Death: Clinical Updates and Perspectives
por: Schupp, Tobias, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0nj9qe6aee9528cfmu34qrp8ga